These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25211588)

  • 1. Excess of nerve growth factor in the ovary causes a polycystic ovary-like syndrome in mice, which closely resembles both reproductive and metabolic aspects of the human syndrome.
    Wilson JL; Chen W; Dissen GA; Ojeda SR; Cowley MA; Garcia-Rudaz C; Enriori PJ
    Endocrinology; 2014 Nov; 155(11):4494-506. PubMed ID: 25211588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excess of ovarian nerve growth factor impairs embryonic development and causes reproductive and metabolic dysfunction in adult female mice.
    Manti M; Pui HP; Edström S; Risal S; Lu H; Lindgren E; Ohlsson C; Jerlhag E; Benrick A; Deng Q; Stener-Victorin E
    FASEB J; 2020 Nov; 34(11):14440-14457. PubMed ID: 32892421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excessive ovarian production of nerve growth factor facilitates development of cystic ovarian morphology in mice and is a feature of polycystic ovarian syndrome in humans.
    Dissen GA; Garcia-Rudaz C; Paredes A; Mayer C; Mayerhofer A; Ojeda SR
    Endocrinology; 2009 Jun; 150(6):2906-14. PubMed ID: 19264868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome.
    Lai H; Jia X; Yu Q; Zhang C; Qiao J; Guan Y; Kang J
    Biol Reprod; 2014 Nov; 91(5):127. PubMed ID: 25100714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
    Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
    Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproductive and metabolic phenotype of a mouse model of PCOS.
    van Houten EL; Kramer P; McLuskey A; Karels B; Themmen AP; Visser JA
    Endocrinology; 2012 Jun; 153(6):2861-9. PubMed ID: 22334715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental androgen excess programs sympathetic tone and adipose tissue dysfunction and predisposes to a cardiometabolic syndrome in female mice.
    Nohara K; Waraich RS; Liu S; Ferron M; Waget A; Meyers MS; Karsenty G; Burcelin R; Mauvais-Jarvis F
    Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1321-30. PubMed ID: 23612996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipocyte dysfunction in a mouse model of polycystic ovary syndrome (PCOS): evidence of adipocyte hypertrophy and tissue-specific inflammation.
    Marino JS; Iler J; Dowling AR; Chua S; Bruning JC; Coppari R; Hill JW
    PLoS One; 2012; 7(10):e48643. PubMed ID: 23119079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-Chiro-Inositol Treatment Affects Oocyte and Embryo Quality and Improves Glucose Intolerance in Both Aged Mice and Mouse Models of Polycystic Ovarian Syndrome.
    Pericuesta E; Laguna-Barraza R; Ramos-Ibeas P; Gutierrez-Arroyo JL; Navarro JA; Vera K; Sanjuan C; Baixeras E; de Fonseca FR; Gutierrez-Adan A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroacupuncture improves metabolic and ovarian function in a rat model of polycystic ovary syndrome by decreasing white adipose tissue, increasing brown adipose tissue, and modulating the gut microbiota.
    Zhang F; Ma T; Tong X; Liu Y; Cui P; Xu X; Shi J; Hu W; Lu W; Pei Z; Xu M; Li X; Xu C; Feng Y
    Acupunct Med; 2022 Aug; 40(4):347-359. PubMed ID: 34892981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acupuncture and exercise restore adipose tissue expression of sympathetic markers and improve ovarian morphology in rats with dihydrotestosterone-induced PCOS.
    Mannerås L; Cajander S; Lönn M; Stener-Victorin E
    Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R1124-31. PubMed ID: 19158405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cinnamon on polycystic ovary syndrome in a mouse model.
    Dou L; Zheng Y; Li L; Gui X; Chen Y; Yu M; Guo Y
    Reprod Biol Endocrinol; 2018 Oct; 16(1):99. PubMed ID: 30340496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine-Cysteine Motif Chemokine Receptor 5 Expression in Letrozole-Induced Polycystic Ovary Syndrome Mice.
    Seow KM; Liu PS; Chen KH; Chen CW; Chen LK; Ho CH; Hwang JL; Wang PH; Juan CC
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology.
    Conway G; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Franks S; Gambineri A; Kelestimur F; Macut D; Micic D; Pasquali R; Pfeifer M; Pignatelli D; Pugeat M; Yildiz BO;
    Eur J Endocrinol; 2014 Oct; 171(4):P1-29. PubMed ID: 24849517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of TGF-β in polycystic ovary syndrome.
    Raja-Khan N; Urbanek M; Rodgers RJ; Legro RS
    Reprod Sci; 2014 Jan; 21(1):20-31. PubMed ID: 23585338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brown adipose tissue activation by rutin ameliorates polycystic ovary syndrome in rat.
    Hu T; Yuan X; Ye R; Zhou H; Lin J; Zhang C; Zhang H; Wei G; Dong M; Huang Y; Lim W; Liu Q; Lee HJ; Jin W
    J Nutr Biochem; 2017 Sep; 47():21-28. PubMed ID: 28501702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.
    Kauffman AS; Thackray VG; Ryan GE; Tolson KP; Glidewell-Kenney CA; Semaan SJ; Poling MC; Iwata N; Breen KM; Duleba AJ; Stener-Victorin E; Shimasaki S; Webster NJ; Mellon PL
    Biol Reprod; 2015 Sep; 93(3):69. PubMed ID: 26203175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infertility in Female Mice with a Gain-of-Function Mutation in the Luteinizing Hormone Receptor Is Due to Irregular Estrous Cyclicity, Anovulation, Hormonal Alterations, and Polycystic Ovaries.
    Hai L; McGee SR; Rabideau AC; Paquet M; Narayan P
    Biol Reprod; 2015 Jul; 93(1):16. PubMed ID: 26040673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.